Fursultiamine
Indication
Used for the treatment of beriberi or Wernicke's encephalopathy caused by vitamin B1 deficiency.
Manufacturer
Minsheng Group Shaoxing Pharmaceutical Co., Ltd.
-
Founded in:
2002-08-08 -
Address:
No. 315, Tang Road, Paojiang Industrial Zone, Shaoxing City, Zhejiang Province -
Tax NO.:
91330600742018162T -
Registered Funds:
88 million yuan -
Website:
-
Email: